WEBINAR: Cystatin C , Creatinine and eGFR Equations
21. Sep 2023 |
6 min read
Cystatin C Webinar Series: CKD-EPI equations
Cystatin C is a superior glomerular filtration rate (GFR) marker for the diagnosis and therapeutic control of renal function1, kidney health2 and Chronic Kidney Disease (CKD). In our Cystatin C webinar series we are now preparing four webinars where we discuss the benefits of cystatin C testing and why the combination of cystatin C and creatinine gives a significant advantage in kidney health and CKD.
In the first webinar Gaute Tangen, Global Product Manager, will talk about the biomarkers Cystatin C and Creatinine in relation to eGFR equations.
A better estimated Glomerular Filtration Rate (eGFR) for all
Cystatin C testing ensures an unbiased assessment of renal function, which is central to the diagnosis and management of chronic kidney disease (CKD). The biomarker has far-reaching benefits across all patient groups, but certain patient populations may experience more benefits. This relates specifically to children, amputees and elderly. These patient groups can receive more accurate eGFRs with testing of cystatin C because cystatin C is less susceptible to factors that influence muscle mass such as age, sex, race, physical activity, etc.3, 4
Clinical use of cystatin C is recommended in guidelines published by KDIGO.5 In the US, a joint task force assembled by the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) has also recommended increased use of cystatin C in combination with creatinine to confirm eGFR and support clinical decision-making.6
Watch webinar: Cystatin C , Creatinine and eGFR Equations
In this webinar you will learn more about:
Disparities in kidney care
Cystatin C for earlier diagnosis of CKD
The recommendation to remove the race factor from creatinine equations
The ideal combination of the two biomarkers cystatin C and creatinine
*This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances.